独家药品概念
Search documents
智飞生物涨2.03%,成交额2.35亿元,主力资金净流出704.70万元
Xin Lang Cai Jing· 2026-02-04 06:51
机构持仓方面,截止2025年9月30日,智飞生物十大流通股东中,香港中央结算有限公司位居第三大流 通股东,持股3356.08万股,相比上期减少278.88万股。易方达创业板ETF(159915)位居第五大流通股 东,持股2415.90万股,相比上期减少405.65万股。华泰柏瑞沪深300ETF(510300)位居第六大流通股 东,持股2042.08万股,相比上期减少96.46万股。招商国证生物医药指数A(161726)位居第九大流通 股东,持股1615.47万股,相比上期减少274.48万股。易方达沪深300医药ETF(512010)位居第十大流 通股东,持股1499.56万股,相比上期减少470.11万股。 声明:市场有风险,投资需谨慎。本文基于第三方数据库自动发布,不代表新浪财经观点,任何在本文 出现的信息均只作为参考,不构成个人投资建议。如有出入请以实际公告为准。如有疑问,请联系 biz@staff.sina.com.cn。 责任编辑:小浪快报 资料显示,重庆智飞生物制品股份有限公司位于重庆市江北区庆云路1号50层,成立日期1995年7月20 日,上市日期2010年9月28日,公司主营业务涉及疫苗、生物 ...
智飞生物涨2.07%,成交额5.20亿元,主力资金净流出3497.44万元
Xin Lang Cai Jing· 2026-01-29 06:51
Core Viewpoint - The stock of Zhifei Biological has shown fluctuations, with a recent increase of 2.07% on January 29, 2023, despite a year-to-date decline of 3.39% [1] Group 1: Stock Performance - As of January 29, 2023, Zhifei Biological's stock price was 18.23 yuan per share, with a trading volume of 5.20 billion yuan and a turnover rate of 2.08%, resulting in a total market capitalization of 436.39 billion yuan [1] - The stock has experienced a 7.05% increase over the last five trading days, but a decline of 3.95% over the last 20 days and 14.37% over the last 60 days [1] Group 2: Financial Performance - For the period from January to September 2025, Zhifei Biological reported an operating income of 76.27 billion yuan, a year-on-year decrease of 66.53%, and a net profit attributable to shareholders of -12.06 billion yuan, reflecting a year-on-year decrease of 156.10% [2] Group 3: Shareholder Information - As of January 20, 2023, the number of shareholders for Zhifei Biological was 121,000, a decrease of 1.56% from the previous period, with an average of 11,686 circulating shares per person, an increase of 1.58% [2] - The company has distributed a total of 73.18 billion yuan in dividends since its A-share listing, with 31.94 billion yuan distributed in the last three years [3] Group 4: Institutional Holdings - As of September 30, 2025, major shareholders include Hong Kong Central Clearing Limited, holding 33.56 million shares, and several ETFs, all of which have seen a decrease in holdings compared to the previous period [3]